Generate Biomedicines, Inc.

NASDAQ:GENB

Asset Management

Financial Services
$10.38 +0.91%

+$0.13 today

Market cap
$1.34B
Beta
0.19
P/E (TTM)
-3.5
EPS (TTM)
-$4.06
52W Low $11.00High $16.75

Volume 1.05M

Average 0.55M

Price history

Generate Biomedicines, Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

-17.94%

Period high

$20.38

Period low

$9.84

Latest

$10.38

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
8-KNov 12, 2026Nov 12, 2026
10-QNov 12, 2026Nov 12, 2026
SC 13GNov 5, 2026Nov 5, 2026
4Nov 4, 2026Nov 4, 2026
4Sep 3, 2026Sep 3, 2026
144Sep 2, 2026Sep 2, 2026
144Sep 1, 2026Sep 1, 2026
8-KAug 26, 2026Aug 25, 2026
10-QAug 6, 2026Aug 6, 2026
8-KAug 6, 2026Aug 6, 2026
SC 13GMay 15, 2026May 15, 2026
SC 13GMay 15, 2026May 15, 2026
10-QMay 7, 2026May 7, 2026
8-KMay 7, 2026May 7, 2026
3Mar 12, 2026Mar 12, 2026

Competitors

Who does Generate Biomedicines, Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about GENB's filings, answered from its disclosures.

What is the latest GENB filing?

The latest filing shown is 10-Q dated Nov 12, 2026.

How many recent filings does GENB have?

Intrinsic Alpha currently shows 20 recent filings for GENB.